An assessment of the safety of adolescent and adult tetanus-diphtheria-acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink

Vaccine

Volumn 27, Issue 32, 2009, Pages 4257-4262

  Yih, W Katherine ^a   Nordin, James D ^b   Kulldorff, Martin ^a   Lewis, Edwin ^c   Lieu, Tracy A ^a,d   Shi, Ping ^a   Weintraub, Eric S ^e  

^a HARVARD PILGRIM HEALTH CARE   (United States)

^b HEALTHPARTNERS RESEARCH FOUNDATION   (United States)

^c KAISER PERMANENTE   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Bacterial vaccines; Sequential analysis; Vaccine safety

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; BRAIN DISEASE; CHILD; CLINICAL ASSESSMENT; CRANIAL NEUROPATHY; DIPHTHERIA; DRUG SAFETY; ENCEPHALITIS; GUILLAIN BARRE SYNDROME; HEALTH SURVEY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MENINGITIS; OUTCOME ASSESSMENT; PARALYSIS; PERTUSSIS; PRIORITY JOURNAL; SCHOOL CHILD; SEIZURE; SEQUENTIAL ANALYSIS; TETANUS;

ADOLESCENT; ADULT; CHILD; CRANIAL NERVE DISEASES; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; ENCEPHALITIS; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; MALE; MENINGITIS; MIDDLE AGED; PARALYSIS; PRODUCT SURVEILLANCE, POSTMARKETING; RISK ASSESSMENT; SEIZURES; YOUNG ADULT;

EID: 67649502292     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.05.036     Document Type: Article

References (21)

1. Centers for Disease Control and Prevention. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep 55 No. RR-3 (2006)
2. Centers for Disease Control and Prevention. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep 55 No. RR-17 (2006)
3. Lloyd J.C., Haber P., Mootrey G.T., Braun M.M., Rhodes P.H., Chen R.T., et al. Adverse event reporting rates following tetanus-diphtheria and tetanus toxoid vaccinations: data from the Vaccine Adverse Event Reporting System (VAERS), 1991-1997. Vaccine 21 (2003) 3746-3750
4. Centers for Disease Control and Prevention. Diphtheria, tetanus, and pertussis: recommendations for vaccine use and other preventive measures: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep 40 No. RR-10 (1991) 1-28
5. Varricchio F., Iskander J., Destefano F., Ball R., Pless R., Braun M.M., et al. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J 23 4 (2004) 287-294
6. Zhou W., Pool V., Iskander J.K., English-Bullard R., Ball R., Wise R.P., et al. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)-United States, 1991-2001. Morb Mortal Wkly Rep Surveill Summ 52 1 (2003) 1-24
7. Davis R.L., Kolczak M., Lewis E., Nordin J., Goodman M., Shay D.K., et al. Active surveillance of vaccine safety: a system to detect early signs of adverse events. Epidemiology 16 (2005) 336-341
8. Lieu T.A., Kulldorff M., Davis R.L., Lewis E.M., Weintraub E., Yih K., et al. Real-time vaccine safety surveillance for the early detection of adverse events. Med. Care 45 Suppl. 2 (2007) S89-S95
9. Stratton K.R., Howe C.J., and Johnston Jr. R.B. Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine. JAMA 271 (1994) 1602-1605
10. Pollard J.D., and Selby G. Relapsing neuropathy due to tetanus toxoid. Report of a case. J Neurol Sci 37 (1978) 113-125
11. Tuttle J., Chen R.T., Rantala H., Cherry J.D., Rhodes P.H., and Hadler S. The risk of Guillain-Barre syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States. Am J Public Health 87 (1997) 2045-2048
12. Centers for Disease Control and Prevention. Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine-United States, June 2005-September 2006. Morb Mortal Wkly Rep 55 (2006) 1120-1124
13. Healthcare Cost and Utilization Project. http://www.hcup-us.ahrq.gov/overview.jsp [accessed August 19, 2008].
14. Kulldorff M, Davis RL, Kolczak M, Lewis E, Lieu T, Platt R. A maximized sequential probability ratio test for drug and vaccine safety surveillance. http://www.dacp.org/maxSPRTsubm.pdf [accessed August 19, 2008].
15. Wald A. Sequential tests of statistical hypotheses. Ann Math Stat 16 (1945) 117-186
16. Kulldorff M. A spatial scan statistic. Commun Stat.: Theory Methods 26 (1997) 1481-1496
17. Murphy T.V., Gargiullo P.M., Massoudi M.S., Nelson D.B., Jumaan A.O., Okoro C.A., et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med 344 8 (2001) 564-572
18. Mullooly J., Drew L., DeStefano F., Chen R., Okoro K., Swint E., et al. Quality of HMO vaccination databases used to monitor childhood vaccine safety. Vaccine Safety DataLink Team. Am J Epidemiol 149 2 (1999) 186-194
19. Mullooly J., Drew L., DeStefano F., Maher J., Bohlke K., Immanuel V., et al. Quality assessments of HMO diagnosis databases used to monitor childhood vaccine safety. Methods Inf Med 43 2 (2004) 163-170
20. Mullooly J.P., Donahue J.G., Destefano F., Baggs J., Eriksen E., and VSD Data Quality Working Group. Predictive value of ICD-9-CM codes used in vaccine safety research. Methods Inf Med 47 4 (2008) 328-335
21. Meeting agenda of the Advisory Committee on Immunization Practices, June 2008. http://www.cdc.gov/vaccines/recs/acip/downloads/agenda-jun08.pdf. Accessed August 19, 2008.